Patents by Inventor Wu-Che Wen

Wu-Che Wen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130158113
    Abstract: The present invention provides methods and compositions for treating brain cancer by cyclohexenone compounds.
    Type: Application
    Filed: June 7, 2012
    Publication date: June 20, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yung LIU, Wu-Che WEN
  • Publication number: 20130005827
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bladder cancer cells and be used as a pharmaceutical composition to inhibit the bladder tumor growth.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20130005825
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of lymphoma cells and be used as a pharmaceutical composition to inhibit the lymphoma tumor growth.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20130005826
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of gastric cancer cells and be used as a pharmaceutical composition to inhibit the gastric tumor growth.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20120322890
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bone cancer cells and be used as a pharmaceutical composition to inhibit the bone tumor growth.
    Type: Application
    Filed: August 28, 2012
    Publication date: December 20, 2012
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Patent number: 8309611
    Abstract: The present invention provides methods and compositions for treating lung cancer by cyclohexenone compounds.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: November 13, 2012
    Assignee: Golden Biotechnology Corporation
    Inventors: Sheng-Yung Liu, San-Bao Hwang, Wu-Che Wen
  • Publication number: 20120277320
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of skin cancer cells and be used as a pharmaceutical composition to inhibit the skin tumor growth.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 1, 2012
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Patent number: 8236860
    Abstract: The present invention relates to a novel application of a compound. The compound 4--2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of pancreatic cancer cells and be used as a pharmaceutical composition to inhibit the pancreatic tumor growth.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: August 7, 2012
    Assignee: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20120071426
    Abstract: The present invention provides methods and compositions for treating lung cancer by cyclohexenone compounds.
    Type: Application
    Filed: March 23, 2011
    Publication date: March 22, 2012
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yung Liu, San-Bao Hwang, Wu-Che Wen
  • Publication number: 20110059122
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of oral cavity cancer cells and be used as a pharmaceutical composition to inhibit the oral cavity tumor growth.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110060056
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of gastric cancer cells and be used as a pharmaceutical composition to inhibit the gastric tumor growth.
    Type: Application
    Filed: September 3, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110060057
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3 -dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of skin cancer cells and be used as a pharmaceutical composition to inhibit the skin tumor growth.
    Type: Application
    Filed: September 3, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110060059
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bladder cancer cells and be used as a pharmaceutical composition to inhibit the bladder tumor growth.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110060055
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of lymphoma cells and be used as a pharmaceutical composition to inhibit the lymphoma tumor growth.
    Type: Application
    Filed: August 30, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110059123
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of colorectal cancer cells and be used as a pharmaceutical composition to inhibit the colorectal tumor growth.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110060058
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of ovarian cancer cells and be used as a pharmaceutical composition to inhibit the ovarian tumor growth.
    Type: Application
    Filed: September 3, 2010
    Publication date: March 10, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110009494
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of pancreatic cancer cells and be used as a pharmaceutical composition to inhibit the pancreatic tumor growth.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Applicant: GOLDEN BIOTECHNOLOGY CORPORATION
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20110009495
    Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bone cancer cells and be used as a pharmaceutical composition to inhibit the bone tumor growth.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Applicant: Golden Biotechnology Corporation
    Inventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
  • Publication number: 20100055216
    Abstract: A method of treating a patient having snoring symptoms is disclosed, which includes administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising Uncaria rhynchophylla material and Cinnamomum cassia Presl material.
    Type: Application
    Filed: November 5, 2009
    Publication date: March 4, 2010
    Applicant: Brion Research Institute of Taiwan
    Inventors: Sheunn-Jyi Sheu, Hsiao-Yin Yeh, Wu-Che Wen, Ching-Che Lin, Chen-Ying Chiang
  • Publication number: 20090208596
    Abstract: A medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal is disclosed. The medical herb composition comprises: Schisandra extract; Ginseng extract; Radix ophiopogonis extract; and Saliva miltiorrhiza extract. The medical herb composition comprising the extracts above is proved to be efficient in enhancing cardiopulmonary function of a mammalian patient without heart disease, enforcing energy and raising strength. The medical herb composition is also capable of reducing the symptoms of breathing difficulties and stagnation of vital energy.
    Type: Application
    Filed: May 4, 2009
    Publication date: August 20, 2009
    Applicant: Brion Research Institute of Taiwan
    Inventors: Shuenn-Jyi Sheu, Hsiao-Yin Yeh, Wu-Che Wen, Ching-Che Lin, Chen-Yin Chiang